Cargando…
Tapentadol, the new kid on the block in India: Is it time to worry?
BACKGROUND AND OBJECTIVES: Large-scale prospective case series of tapentadol abuse or dependence in India is not available. Hence, we aimed to study the prevalence and profile of tapentadol users in a treatment-seeking population. MATERIALS AND METHODS: The study had prospective and retrospective ar...
Autores principales: | Basu, Debasish, Mahintamini, Tathagata, Ghosh, Abhishek, Roub, Fazle, Subodh, B. N., Mattoo, S. K., Avasthi, Ajit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052882/ https://www.ncbi.nlm.nih.gov/pubmed/33896976 http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_332_20 |
Ejemplares similares
-
Course and Correlates of Stigma in Patients on Opioid Agonist
Treatment: A Prospective Study from an Outpatient Treatment Program in
India
por: Ghosh, Abhishek, et al.
Publicado: (2021) -
Telemedicine-assisted stepwise approach of service delivery for substance use disorders in India
por: Ghosh, Abhishek, et al.
Publicado: (2021) -
Buprenorphine-based opioid substitution therapy in India: A few observations, thoughts, and opinions
por: Ghosh, Abhishek, et al.
Publicado: (2018) -
Opioid substitution therapy with buprenorphine-naloxone during COVID-19 outbreak in India: Sharing our experience and interim standard operating procedure
por: Basu, Debasish, et al.
Publicado: (2020) -
Service users’ perception and attitude toward telemedicine-based treatment for substance use disorders: A qualitative study from India
por: Ghosh, Abhishek, et al.
Publicado: (2023)